#USA #New York #Inc. #Calumet #Pomerantz LLP #CLMT

Investor Alert: Pomerantz Law Firm's Ongoing Investigation into Calumet, Inc.

The Pomerantz Law Firm, a well-regarded name in the sector of corporate and securities litigation, has initiated an investigation surrounding allegations from investors of Calumet, Inc., a notable player in the industry listed under the NASDAQ stock exchange as CLMT. The firm is calling on any affected investors to reach out for guidance regarding their potential claims.

This scrutiny is primarily focused on whether Calumet and its executives may have engaged in securities fraud or other unethical business practices that could have misled investors. Given the importance of transparency in corporate governance, such investigations remain critical for ensuring that businesses uphold their fiduciary responsibilities.

Recent disclosures from Calumet have raised alarms among stakeholders. On August 7, 2026, the company delivered its financial results for the second quarter, revealing concerning trends in its Performance Brands division. Notably, there was a year-on-year decrease in adjusted EBITDA by $6.2 million, attributed mainly to timing issues as input costs surged before corresponding price adjustments were made. This resulted in a $7 million deficit from LIFO accounting methods. Furthermore, Calumet's Montana Renewables segment reported a substantial loss, around $40 million, due to downtime caused by the MaxSAF expansion and turnaround. The limited output led to an adjusted EBITDA contribution of only $17 million.

The announcement of these results had an immediate impact on the company's stock, with a drop of $2.40 per share, translating to a 5.73% decrease, concluding at $39.48 on the day of disclosure. This sharp decline underscores the investor community's sensitivity to the financial health and operational performance of the company.

The implications of these financial results are severe, as Calumet also indicated a deferment in the full-scale production of SAF (Sustainable Aviation Fuel). This postponement is purportedly aimed at enhancing further EBITDA capture at the conventional refinery level before adjustments to the production framework. Such strategic shifts inevitably bring further uncertainties in operational yield and revenue generation for stakeholders.

Pomerantz LLP has established itself as a leading institution in the realm of class-action lawsuits linked to securities, having a legacy that spans over eight decades. Founded by the late Abraham L. Pomerantz, often dubbed the father of securities class actions, the firm has a rich history of defending the rights of investors who have fallen victim to corporate misconduct. Over the years, they have successfully reclaimed substantial damage awards, reinforcing their commitment to justice within the investment community. Through this investigation, Pomerantz continues its tradition of advocating for investors' rights, especially in instances of alleged breaches of fiduciary duty and fraudulent practices.

Take Action

If you have invested in Calumet, Inc., it is advisable to consider your options carefully and stay informed about the ongoing developments of this investigation. Danielle Peyton from Pomerantz Law Firm is available for consultations and can be reached at [email protected] or at 646-581-9980, ext. 7980.

This ongoing investigation not only highlights potential irregularities at Calumet, but it also serves as a reminder to investors about the importance of due diligence and remaining vigilant in monitoring their investments.

For more details about the investigation or to join the class action lawsuit, interested parties can visit Pomerantz's official site or contact the firm directly.

In an era where corporate accountability is under the spotlight more than ever, understanding the complexities and dynamics of such investigations is pivotal for safeguarding investor interests and promoting ethical business conduct.